申请人:Dong Wha Pharm. Ind. Co., Ltd.
公开号:US06150390A1
公开(公告)日:2000-11-21
The present invention relates to a novel 3-amino-1,2-benzoisoxazole derivatives, represented by Formula I, LTB-4[leukotriene-B-4; 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid] receptor antagonist, process for preparation thereof, and use thereof for LTB-4 receptor antagonist or therapeutics for osteoporosis. ##STR1## (in which n is integer of 3-5).
本发明涉及一种新型的3-氨基-1,2-苯并异噁唑衍生物,由式I表示,即LTB-4[白三烯-B-4; 5(S),12(R)-二羟基-6,14-顺式-8,10-反式-二十碳四烯酸]受体拮抗剂,其制备方法以及用途,用于LTB-4受体拮抗剂或治疗骨质疏松症。##STR1##(其中n为3-5的整数)。